Infertility Drugs Market Report, Size, Share, Growth & Trends 2023 to 2028

The latest research study “Infertility Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” by IMARC Group, finds that the global infertility drugs market size reached US$ 3.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.24% during 2023-2028.

Infertility drugs are medications designed to treat infertility and boost reproductive health. They can be administered orally or through injections and are available in various types. Some commonly used infertility drugs include gonadotrophins, selective estrogen receptor modulators (SERMs), aromatase inhibitors, dopamine agonists, biguanides, ovulatory stimulants, and tricyclic antidepressants. They promote ovulation and follicle development of the ovary in women while improving the quality of sperm in men and restoring their testosterone levels. As a result, infertility drugs are gaining immense traction among couples struggling to conceive across the globe.

Request for a Free Sample Copy of This Report: https://www.imarcgroup.com/infertility-drugs-market/requestsample

Infertility Drugs Market Trends:

The global infertility drugs market is primarily driven by rising rates of infertility and miscarriage. Moreover, several favorable initiatives by governments of numerous countries to raise awareness about the available treatment options for infertility are positively influencing market growth. Additionally, the rising prevalence of chronic diseases, such as cancer, obesity, diabetes, thyroid, polycystic ovarian syndrome (PCOS), and menopausal disorders, due to hectic work schedules, stress, and lifestyle changes is another major growth-inducing factor. Furthermore, the easy availability of public funding for drug development and faster drug approvals from regulatory bodies are contributing to market growth. Other factors, including rising demand for generic medicines, improving healthcare infrastructure, and rapid urbanization, are also anticipated to drive the market further.

Infertility Drugs Market 2023-2028 Competitive Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Major Players Covered:

Abbott Laboratories
Bayer AG
Ferring Pharmaceuticals
Merck & Co. Inc.
Merck KGaA
Novartis AG
Pfizer Inc.
Livzon Pharmaceutical Group Inc.
Mankind Pharma
Sanofi S.A.
Theramex.

Key Market Segmentation:

The report has segmented the market on the basis of drug class, route of administration, distribution channel, end user and region.

Breakup by Drug Class:

Gonadotropin
Aromatase Inhibitors
Selective Estrogen Receptor Modulators (SERMs)
Biguanides
Others

Breakup by Route of Administration:

Oral
Intravenous
Subcutaneous
Intramuscular

Breakup by Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Others

Breakup by End User:

Male
Female

Breakup by Region:

North America
Asia Pacific
Europe
Latin America
Middle East and Africa

Click here to view detailed information with table of content: https://www.imarcgroup.com/infertility-drugs-market

Key highlights of the report:

• Market Performance (2017-2022)

• Market Outlook (2023-2028)

• Porter’s Five Forces Analysis

• Market Drivers and Success Factors

• SWOT Analysis

• Value Chain

• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact:

Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St.
City: Brooklyn
State: NY
Country: United States